Login
Register
CVRF's Meetings
TCTAP AP VALVES COMPLEX PCI

SummitMD

AP VALVES & STRUCTURAL HEART 2022

Home
News
Videos
Topics
Book
Conferences
About CVRF

Topics Coronary

Home
Topics

Slide

PCSK9 Inhibitor: Effect of Alirocumab on CV Events and Mortality After ACS

- Presenter : Hanbit Park

Leave a comment

Sign in to leave a comment.

Category

Coronary

Left Main
Bifurcation
CTO
Long Lesion
Ostial
In-stent Restenosis
Others

Endovascular

Carotid
Peripheral Disease
- SFA
- BTK
- Iliac
- Poplitial
- Subclavian
Abdominal Aorta
Renal
Others

Structural Heart Disease

Congenital Heart Disease
HOCM
Others

Valve

TAVR
Others

Imaging & Physiology

Antiplatelet
Anticoagulant
Lipid and Inflammation
Others

Pharmacology

Antiplatelet
Anticoagulant
Lipid and Inflammation
Others

Conference

TCTAP
AP VALVES
COMPLEX PCI

Upcoming Events

11th
AP VALVES & SH 2022
August 11-12, 2022
Grand Walkerhill Seoul, Korea
7th
COMPLEX PCI 2022
November 24-25, 2022
Grand Walkerhill Seoul, Korea
28th
TCTAP 2023
April 22-25, 2023
Coex, Seoul, Korea

CardioVascular Research Foundation

2F Asan Institute for Education & Research, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
Business Registration Number: 215-82-06387

Privacy PolicyContact Us

The Latest News

2 East Asian studies helped uncover treatment data for understudied stroke patients
22-03-11
Oscillating history of heart xenotransplantation strikes forward with breakthrough operation
22-02-11
PCI vs. CABG debate continues in left main after meta-analysis shows tradeoffs, no clear winner
22-01-28

Sign up for CVRF e-newsletter

Copyright 2002. All Rights Reserved.